Fig. 6.
Fig. 6. Increases by LPS in the soluble EPCR levels in rats that can be blocked by hirudin. / (A) Serum from normal controls (n = 6), rats given LPS (n = 4), and rats given LPS plus hirudin (n = 6) at 0, 3, and 6 hours after administration of the agents were assayed for soluble EPCR levels by enzyme-linked immunosorbent assay (ELISA). (B) Changes in soluble EPCR levels in rats infused with bovine thrombin or hirudin alone. (C) Rats were injected with LPS (20 mg/kg) through the tail vein. Serum samples were collected at the indicated times through the tail vein and were assayed for the soluble EPCR by ELISA. In the 2 animals that died, the last data point corresponds to the serum sample obtained at the time of death.

Increases by LPS in the soluble EPCR levels in rats that can be blocked by hirudin.

(A) Serum from normal controls (n = 6), rats given LPS (n = 4), and rats given LPS plus hirudin (n = 6) at 0, 3, and 6 hours after administration of the agents were assayed for soluble EPCR levels by enzyme-linked immunosorbent assay (ELISA). (B) Changes in soluble EPCR levels in rats infused with bovine thrombin or hirudin alone. (C) Rats were injected with LPS (20 mg/kg) through the tail vein. Serum samples were collected at the indicated times through the tail vein and were assayed for the soluble EPCR by ELISA. In the 2 animals that died, the last data point corresponds to the serum sample obtained at the time of death.

Close Modal

or Create an Account

Close Modal
Close Modal